.svg){kind=logo}
A Practical Guide to Microdosing GLP-1
Most people who look into GLP-1 medication have heard the same two stories: dramatic weight loss, or miserable side effects. Microdosing sits between them. A lower, clinician-set dose aims at steadier appetite signals, more predictable energy, and better tolerability — traded against a slower, smaller change on the scale.
What “microdosing” actually means here
It means a subtherapeutic dose — below the standard titration schedule a manufacturer lists for weight management — prescribed and adjusted by a licensed clinician. There is no official microdose protocol, and no regulator has defined the term. What varies between providers is how willing their prescribers are to start low, hold a dose, and adjust to your response instead of moving you up the ladder on a fixed timetable.
People generally come to it for one of a few reasons:
- They tolerated a standard dose poorly, usually gastrointestinal side effects
- They want appetite regulation without aggressive weight loss
- They are maintaining after reaching a goal weight
- Cost — a smaller dose can stretch a supply further
What the evidence does and does not say
Be skeptical of confident claims in either direction. GLP-1 receptor agonists are well-studied at their labeled doses; low-dose protocols used for general wellness are not. What is reasonably established is that effects are dose-dependent, and that side effects typically scale with dose — which is the mechanism microdosing leans on. What is not established is a specific wellness benefit at subtherapeutic doses, and no provider should tell you otherwise.
Compounded GLP-1/GIP formulations, which most microdose programs dispense, are prepared by licensed pharmacies under physician supervision and are not FDA-approved. That is not the same as illegal or unsafe, but it does mean the specific product you receive has not gone through the approval process the branded versions did. Ask which pharmacy compounds it and whether third-party potency testing is done.
How the programs differ
On paper the offers look alike — online intake, clinician review, medication shipped to your door. The differences that matter show up after you have signed up:
- Dose personalization — can your prescriber hold you at a low dose indefinitely, or does the program assume standard titration?
- What the price includes — some quote a flat all-in monthly rate; others charge a program fee with medication billed separately. Compare the total, not the headline.
- Ongoing access — whether you can message a clinician between refills, and how quickly adjustments actually happen.
- Cancellation terms — month-to-month versus a commitment, and what happens to unshipped medication you have paid for.
Before you start
GLP-1 medication is not appropriate for everyone. Personal or family history of medullary thyroid carcinoma or MEN2, pancreatitis, gallbladder disease, or pregnancy all change the calculation, and a legitimate provider will screen for them. If an intake takes ninety seconds and never asks about your history, that tells you what kind of program it is.
The rankings above weigh exactly these factors — dosing flexibility, clinician access, pharmacy sourcing, and honest pricing. Nothing here is medical advice; it is a starting point for a conversation with a clinician who can see your full picture.